Header Logo

Connection

NAGESHWARA V. DASARI to Trifluridine

Back to Details
This is a "connection" page, showing publications NAGESHWARA V. DASARI has written about Trifluridine.
NAGESHWARA V. DASARI
Connection Strength
0.220
Trifluridine
  1. Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study. Lancet. 2023 07 01; 402(10395):41-53.
    View in: PubMed
    Score: 0.220
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.